Skip to main content
Brie Carter Photo
Brie Carter

Brie Carter

GrafaTV Presenter & Finance Editor

TV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.

Articles by Brie Carter

Grafa
Health

Agilent secures FDA nod for first-of-its-kind ovarian cancer diagnostic

Agilent Technologies (NYSE:A) announced today that the U.S. Food and Drug Administration (FDA) has approved its PD-L1 IHC 22C3 pharmDx as the first and only companion diagnostic to identify first-line patients with epithelial ovarian cancer (EOC) eligible for Merck’s blockbuster immunotherapy, KEYTRUDA.

Read more: Agilent secures FDA nod for first-of-its-kind ovarian cancer diagnostic